COMPASS Pathways

CMPSNasdaq United Kingdom Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.079 B

$15.01 -1.19%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$269.8M

Loss-making

Shares outstanding

138,476,822

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#107UroGen PharmaURGN$2.11B
#108Bausch Health CompaniesBHC$2.11B
#109COMPASS PathwaysCMPS$2.08B
#110Agios PharmaceuticalsAGIO$2.03B
#111PERRIGOPRGO$1.96B

What if COMPASS Pathways were worth as much as…

Open the what-if tool →

Gold $30.3T

$218,621.81

Per share 14,565× higher

Bitcoin $1.72T

$12,419.43

Per share 827× higher

Nvidia $5.48T

$39,572.38

Per share 2,636× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for COMPASS Pathways are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.